首页 | 本学科首页   官方微博 | 高级检索  
检索        

中西医结合治疗晚期非小细胞肺癌疗效观察
引用本文:沈德美,许凤.中西医结合治疗晚期非小细胞肺癌疗效观察[J].上海中医药杂志,2005,39(8):5-6.
作者姓名:沈德美  许凤
作者单位:上海市浦东新区公利医院肿瘤内科,上海,200135
摘    要:观察中药联合化疗治疗晚期非小细胞肺癌的疗效。晚期非小细胞肺癌72例随机分为治疗组40例和对照组32例。对照组单用NP方案,治疗组在此基础上加用中药益气养阴为主,疗程8周。结果:治疗组有效率为52.5%,对照组为31.3%,(P〈0.01)。治疗组1年、2年、3年生存率分别为57.5%,27.5%和12.5%,中位生存期18个月;对照组分别为25.0%、9.4%和3.1%,中位生存期11个月。治疗组疗效明显高于对照组。提示中药加化疗治疗晚期非小细胞肺癌的生存期优于对照组.

关 键 词:晚期非小细胞肺癌  中西医结合疗法  益气养阴  化学疗法  生存期
文章编号:1007-1334(2005)08-0005-02
收稿时间:2005-05-10
修稿时间:2005年5月10日

Clinical Observation of Combined Chinese and Western Medicine in Treating Non-small Cell Lung Cancer
SHEN De-mei,XU Feng.Clinical Observation of Combined Chinese and Western Medicine in Treating Non-small Cell Lung Cancer[J].Shanghai Journal of Traditional Chinese Medicine,2005,39(8):5-6.
Authors:SHEN De-mei  XU Feng
Abstract:To observe the clinical efficacy of Chinese medicine plus chemotherapy in the treatment of non-small cell lung cancer, 72 subjects were randomized into two groups:control group in which 32 cases were treated by NP program and treatment group in which 40 cases were treated by NP program and " Yiqi Yang-yin Jianpi Decoction" , with a course of 4 - 8 weeks. Results: The effective rate was 52. 5% in treatment group and 31. 3% in control group,P < 0. 01 ; in treatment group, the one-year, two-year and three-year survival rates were 57. 5% , 27. 5% and 12.5% respectively, with a median survival period of 18 months; in control group, they were 25% , 9.4% and 3.1% , with a median survival period of 11 months. The rates were higher in treatment group than in control group, it is indicated that Chinese medicine plus chemotherapy may delay the survival period of non-small cell lung cancer patients.
Keywords:Non-small cell lung cancer  Chinese medicine  qi-yin-enriching therapy  ehemotherapy  survival period
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号